Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent, which is well established with U.S. clinical experience since 1986. Worldwide, more than 250 million doses of iopamidol have been administered, the company said.
Indicated for a wide variety of radiological procedures, Isovue offers flexibility by providing a wide range of iodine concentrations and packaging options. Isovue prefilled syringes for use with the Medrad injection systems provide efficient contrast media use and administration convenience. Isovue-370 is the highest concentration of contrast approved for CT in the U.S. and is an excellent agent to match the speed and power of MDCT.
Nonionic iodinated contrast media inhibit blood coagulation, in vitro, less than ionic contrast media. Clotting has been reported when blood remains in contact with syringes containing nonionic contrast media, the company said.
August 17, 2023 
